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Abstract
Background: Hundreds of studies of maternity care interventions have been published, too many for most people
involved in providing maternity care to identify and consider when making decisions. It became apparent that
systematic reviews of individual studies were required to appraise, summarise and bring together existing studies
in a single place. However, decision makers are increasingly faced by a plethora of such reviews and these are
likely to be of variable quality and scope, with more than one review of important topics. Systematic reviews (or
overviews) of reviews are a logical and appropriate next step, allowing the findings of separate reviews to be
compared and contrasted, providing clinical decision makers with the evidence they need.
Methods: The methods used to identify and appraise published and unpublished reviews systematically, drawing
on our experiences and good practice in the conduct and reporting of systematic reviews are described. The
process of identifying and appraising all published reviews allows researchers to describe the quality of this
evidence base, summarise and compare the review’s conclusions and discuss the strength of these conclusions.
Results: Methodological challenges and possible solutions are described within the context of (i) sources, (ii) study
selection, (iii) quality assessment (i.e. the extent of searching undertaken for the reviews, description of study
selection and inclusion criteria, comparability of included studies, assessment of publication bias and assessment of
heterogeneity), (iv) presentation of results, and (v) implications for practice and research.
Conclusion: Conducting a systematic review of reviews highlights the usefulness of bringing together a summary
of reviews in one place, where there is more than one review on an important topic. The methods described here
should help clinicians to review and appraise published reviews systematically, and aid evidence-based clinical
decision-making.
Background
The healthcare literature contains hundreds of thou-
sands of studies of healthcare interventions, growing at
tens of thousands per year [1]. In most areas of health
care, there are too many studies for people involved in
providing care to identify and consider when making
decisions. Researchers have recognised this problem and
many have accepted the challenge of preparing systema-
tic reviews of individual studies in order to appraise,
summarise and bring together existing studies in a sin-
gle place. More recently, calls have been made for ‘rapid
reviews’ to provide decision-makers with the evidence
they need in a shorter time frame, but the possible
limitations of such ‘rapid reviews’, compared to full sys-
tematic reviews, require further research [2]. There are
now several organisations dedicated to the preparation
of systematic reviews, including the National Institute of
Health and Clinical Excellence (NICE) in the UK, the
Evidence-based Practice Centre Program, funded by
AHRQ in the USA, the Joanna Briggs Institute, and the
international Campbell and Cochrane Collaborations,
with the latter being the largest single producer of sys-
tematic reviews in health care, with more than 4200
published by the end of 2010 [3]. In recent years how-
ever, decision makers who were once overwhelmed by
the number of individual studies have become faced by
a plethora of reviews [4,5]. These reviews are likely to
be of variable quality and scope, with more than one
systematic review on important topics. For example, a
comprehensive search of twelve health related citation
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identified over thirty reviews evaluating the effectiveness
of nurse and midwife-led interventions on clinical out-
comes, as part of an on-going study into the impact of
the role of nurse and midwife specialist and advanced
practitioners in Ireland. A logical and appropriate next
step is to conduct a systematic review of reviews of the
topic under consideration, allowing the findings of sepa-
rate reviews to be compared and contrasted, thereby
providing clinical decision makers with the evidence
they need. We have been involved in several examples
of systematic reviews (or overviews) of reviews [6-9]
and The Cochrane Collaboration introduced a new type
of Cochrane review in 2009 [10], the overview of
Cochrane reviews, with two full overviews [11,12] and
protocols for five more [13-17] published by October
2010. These reviews of reviews aims to provide a sum-
mary of evidence from more than one systematic review
at a variety of different levels, including the combination
of different interventions, different outcomes, different
conditions, problems or populations, or the provision of
a summary of evidence on the adverse effects of an
intervention [10].
This paper describes the conduct and methods used to
identify and appraise published and unpublished sys-
tematic reviews systematically. It draws on our experi-
ence of conducting several of these reviews of reviews in
recent years. The purpose of such an overview, in iden-
tifying and appraising all published reviews is to
describe their quality, summarise and compare their
conclusions and discuss the strength of these conclu-
sions, so that best evidence is made available to clinical
decision-makers. During the review process a number of
methodological challenges can arise. We describe these
challenges and offer possible solutions to overcome
them. We hope to provide a guide to clinicians and
researchers who wish to conduct a systematic review of
reviews and to share our experiences.
Methods
The objective and the reasons for conducting a systema-
tic review of reviews should be made explicit at the start
of the process, as this is likely to influence the methods
used for the review. In formulating the scope for the
review of reviews, the PICOS (participants, interven-
tions, comparators, outcomes, and study design) struc-
ture may be helpful. This can help the reviewers to
delineate clearly if they wish, for example, to compare
and summarise systematic reviews that address the same
treatment comparison or a particular intervention for a
population or condition, or a range of interventions for
people with a specific condition. Following this, the
methods in conducting a systematic review of reviews
require consideration of the following aspects, akin to
the planning for a systematic review of individual stu-
dies: sources, review selection, quality assessment of
reviews, presentation of results and implications for
practice and research.
Sources and searching
Locating and retrieving relevant literature is challenging,
yet crucial to the success of a systematic review. The
material sourced provides the information from which
evidence, conclusions and recommendations are drawn.
For many, the literature search may appear overwhelm-
ing, given the sheer volume of material to check
through. However, establishing a systematic search strat-
egy, before commencing the literature search, is funda-
mental to appropriate and successful information
retrieval. This planning assists in meeting the require-
ments of the systematic review and in answering the
research question. In developing a search strategy, the
scope of the search, its thoroughness and the time avail-
able to conduct it, all need to be considered. The aim is
to ensure that the systematic review of reviews is com-
prehensive, thorough and objective.
The methods used in sourcing relevant literature to
conduct a systematic review of reviews are similar to
those adopted in conducting a systematic review of indi-
vidual studies with some subtle differences described
here. A realistic time-frame to conduct the systematic
review of reviews should be established. It has been esti-
mated that a typical systematic review would take
between six and eighteen months [18] but this is very
dependent on the research question and the staffing,
funding and other resources available. The process
might be faster for a systematic review of reviews if the
time-frame to complete the literature search is signifi-
cantly reduced through the ability to target the search-
ing of articles most likely to be reports of a systematic
review. In a systematic review of individual studies, the
search should be as wide as possible to maximize the
likelihood of capturing all relevant data and minimizing
the effects of reporting biases. A search of a variety of
electronic databases relevant to the topic of interest is
recommended [18]. However, in a systematic review of
reviews, it may be possible to limit the searches to data-
bases specific to systematic reviews such as the
Cochrane Database of Systematic Reviews and the Data-
base of Abstracts of Reviews of Effects. Likewise,
although the search for a review of individual studies
might need to cover many decades [19], limiting the
search to period from the early 1990 s onwards is likely
to identify all but the very small minority of systematic
reviews conducted before then [20,21]. Furthermore,
researchers might find that identifying and highlighting
a recent high quality systematic review will prove of
most benefit to decision makers using their review or
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still prove helpful if these contain relevant information
that is not included in the recent review. Applying lan-
guage restrictions is not recommended; but, unavoidable
constraints such as a lack of access to translation ser-
vices or funds to pay for these may make it necessary to
restrict the systematic review or reviews to English lan-
guage publications. In such instances, this limitation
should be acknowledged when reporting the review and
it might be worthwhile reporting the difference between
searches with and without language restrictions in order
to estimate the amount of literature that might have
been excluded.
The search terms used for the literature search should
be clearly described, with information on their relevance
to the research question. Furthermore, search terms
should be focused so that they are broad enough in
scope to capture all the relevant data yet narrow enough
to minimize the capture of extraneous literature that
may result in unnecessary time and effort being spent
assessing irrelevant articles. In conducting a systematic
review of reviews, systematic reviews rather than indivi-
dual studies are of interest to the reviewer and several
search strategies have been developed to identify this
type of research [22,23] which could be combined with
the terms for the relevant healthcare topic. In develop-
ing the search strategy for a systematic review of
reviews, researchers might wish to consider the PRESS
initiative, developed as a means for peer reviewing lit-
erature searches [24] to check that the various elements
of the electronic search strategy have been considered.
To minimize the risk of missing relevant reviews, a
manual search of key journals and of the reference lists
of reviews captured by the initial searches is also recom-
mended. The literature search can also be complemen-
ted by contacting experts in the topic under review and
by checking articles which cite individual studies that
are known to be relevant to the topic. This may prove
relevant in learning of published systematic reviews that
are not indexed in the bibliographic databases searched,
and of ongoing systematic reviews near completion. The
development of a prospective register of systematic
reviews should help further with this [25].
Review Selection
A major challenge to review selection is identifying all
reviews relevant to the topic of interest, and of potential
importance to answering the research question. During
the planning phase, before commencing the systematic
review of reviews, a review team should be established.
The review team should include at least one person
with methodological expertise in conducting systematic
reviews and at least one person with expertise on the
topic under review. The review team is responsible for
developing a review selection strategy. An agreement of
inclusion and exclusion criteria should be made before
starting the review selection process. Aspects of this
process might include decisions regarding the type of
reviews that may be included in the systematic review.
For example, in our review on interventions for prevent-
ing preterm birth [6], we restricted the inclusion criteria
to reviews of randomized controlled trials. Another
example of inclusion criteria might be to limit the sys-
tematic review of reviews to reviews of a particular type
of participant (such as women having their first baby) or
which assess a particular type of pain relief.
When a selection strategy has been developed, the
selection process is carried out in a similar way to a
review of individual studies:
￿ Assess retrieved titles and abstracts for relevance
and duplication.
￿ Select those you wish to retrieve and appraise
further.
￿ Obtain full text copies of these potentially eligible
reviews.
￿ Assess these reviews for relevance and quality; ide-
ally, using independent assessment by at least two
members of the review team. This reduces bias in
review selection and allows for appropriate discus-
sion should uncertainty arise.
Quality Assessment of Reviews
The quality and strength of evidence presented in the
individual, included reviews should influence the conclu-
sions drawn in the systematic review of these. The qual-
ity and scope of published reviews varies widely. The
strength of the conclusions and the ability to provide
decision-makers with reliable information depends on
the inclusion of reviews that meet a minimum standard
of quality. When assessing the quality of the reviews,
one should try to avoid being influenced by extraneous
variables, such as authors, institutional affiliations and
journal names; and should focus on the quality of the
conduct of the review. Although the researchers will
usually have to do this via an assessment of the quality
of report, with the hope that initiatives such as PRISMA
(formerly, QUOROM) which assist by facilitating ade-
quate standards of reporting [26].
The AMSTAR tool [27], which became available after
we started work on our review of reviews, is the only
tool that we are aware of that has been validated as a
means to assess the methodological quality of systematic
reviews and could be used in the review of reviews to
determine if the potentially eligible reviews meet mini-
mum requirements based on quality. While the authors
of the AMSTAR paper [27] recognise the need for
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identified within the tool are: establishing the research
question and inclusion criteria before the conduct of the
review, data extraction by at least two independent data
extractors, comprehensive literature review with search-
ing of at least two databases, key word identification,
expert consultation and limits applied, detailed list of
included/excluded studies and study characteristics,
quality assessment of included studies and consideration
of quality assessments in analysis and conclusions,
appropriate assessment of homogeneity, assessment of
publication bias and a statement of any conflict of
interest.
Although our review of reviews began before the pub-
lication of the AMSTAR tool, we used similar domains
to assess review quality. Our assessment criteria are
shown below and provide a structure that can be used
to report the quality and comparability of the included
reviews to help readers assess the strength of the evi-
dence in the review of reviews:
▪ The extent of searching undertaken: Are the data-
bases searched, years searched and restrictions
applied in the original review clearly described?
I n f o r m a t i o no nt h ee x t e n tof searching should be
clearly provided, to allow for a comprehensive
assessment of the scope of the review.
▪ Description of review selection and inclusion cri-
teria: Do the authors of the original review provide
details of study selection and eligibility criteria and
what are these details? This information should be
clearly reported in the systematic review of reviews.
▪ Assessment of publication bias: Did the authors of
the original review seek additional information from
authors of the studies they included? Are there any
details of statistical tests (such as funnel plot analy-
sis) to assess for publication bias?
▪ Assessment of heterogeneity: Did the authors of the
original review discuss or provide details of any tests
of heterogeneity? In the presence of significant het-
erogeneity, were statistical tests used to address this?
▪ Comparability of included reviews: Are the reviews
comparable in terms of eligibility criteria, study
characteristics and primary outcome of interest? For
example, in our review of reviews on fetal fibronec-
tin and transvaginal cervical ultrasound for predict-
ing preterm birth, [8] we included reviews that had
incorporated studies among women who were both
symptomatic and asymptomatic for preterm birth.
As a means of addressing comparability of the
included reviews, we provided details of the number
of women in each group separately and reported the
results for each group separately, where applicable.
Presentation of Results
When the results of a systematic review of reviews are
presented, this should present the reader with the major
conclusions of the review through the provision of
answers to the research question, as well as the evidence
on which these conclusions are based and an assessment
of the quality of the evidence supporting each conclu-
sion; for example, using the GRADE approach as
adopted for the ‘Summary of Findings’ table in
Cochrane reviews [28]. It is important to be specific in
reporting the primary outcome of interest for the
review, and this can reduce workload by limiting data
extraction to only those results relevant to the topic of
interest from reviews that report on several outcome
measures. For example, some systematic reviews on
antibiotic therapy for the prevention of preterm birth
[29,30] report a variety of outcome measures other than
preterm birth (e.g. neonatal outcomes). However, in our
systematic reviews of reviews [6,8], our research focus
on preterm birth meant that only results for the effects
on preterm birth were extracted.
The use of summary tables and figures is helpful in
presenting results in a structured and clear format that
will enhance textual commentary. Table 1 is an example
of the provision of details of the scope of the reviews
included in a systematic review of reviews (3). Sources
of evidence and some quality assessment criteria are
included. The quality assessment is enhanced by a nar-
rative discussion of heterogeneity and publication bias.
Table 2 provides an example of how summary results
from each original review might be presented in the sys-
tematic review of reviews.
The use of a checklist or reporting tool may also guide
the reviewer when reporting on a systematic review of
reviews. Although we did not identify a tool specific to
reporting of systematic reviews of reviews, the PRISMA
statement provides a useful framework to follow [26].
This guidance, developed for reporting systematic
reviews and meta-analyses of studies that evaluate
healthcare interventions, can be used to assess item
inclusion in a systematic review of systematic reviews.
Implications for practice and research
O n eo ft h ep r o b l e m sf a c e db yd e c i s i o nm a k e r sw h o
encounter multiple reviews o ft h es a m et o p i ci si n c o n -
sistency in the results or conclusions of these reviews.
Jadad et al (1997) provide guidance on how to address
discordant results from individual reviews [31] and con-
ducting systematic reviews of reviews will help to
address this issue further. A systematic review of reviews
can provide reassurances that the conclusions of indivi-
dual reviews are consistent, or not. The quality of indivi-
dual reviews may be assessed, so that evidence from the
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together in a single document, providing definitive sum-
maries that could be used to inform clinical practice.
Discussion
Meta-analyses in systematic reviews of reviews
A major challenge in conducting a systematic review of
reviews is the creation of a ‘meta-analysis’ of the
included reviews, which are themselves meta-analyses.
In doing this, it is important that data from individual
studies are not used more than once. This would give
too much statistical power, with the risk that a mislead-
ing estimate will be produced and that this will be
overly precise. Overcoming this challenge would require
the unpicking of each of the included reviews and the
subsequent combination of the results of the individual,
included studies. This mayp r o v et ob eac o m p l e xa n d
time-consuming task and careful consideration should
Table 1 Summary table of scope of reviews in a systematic review of reviews
1
Review
Year
Aim (participants) Search strategy No. of
studies
included
Total no. of
participants
Timing of
preventative
strategy
King &
Flenady
2002
To assess the effects of prophylactic
antibiotics on preterm labour (women
symptomatic for preterm labour)
Cochrane Pregnancy & Childbirth
Group (May 2002)
Search terms provided.
No language restrictions
11 7428 (6295 enrolled
in one trial)
Mean gestational age
at entry to all trials 30-
32 weeks (but varied
across studies)
Simcox
et al
2007
To determine if antibiotics reduce the
risk of preterm birth (asymptomatic
women at risk, e.g. previous preterm
birth or positive fibronectin status)
Cochrane Pregnancy & Childbirth
Group (2005)
Search terms provided.
English language publications.
17 1291 12-28 weeks across
studies
1Reprinted from the European Journal of Obstetrics & Gynecology and Reproductive Biology, Volume 142, Smith V, Devane D, Begley CM, Clarke M, Higgins S.A
systematic review and quality assessment of systematic reviews of randomised trials of interventions for preventing and treating preterm birth. 3-11, Copyright
(2009), with permission from Elsevier.
Table 2 Summary of results reported in a systematic review of reviews
2
Review Tocolytic agent Birth >48 hrs
(95% CI)
Birth >7 days
(95% CI)
Birth >34 weeks
(95% CI)
Birth >37 weeks
(95% CI)
King 1988 Betamimetics compared with placebo or
no treatment
12 trials
OR 0.59, (0.42-0.83)
Significant
- - 8 trials
OR 0.71
(0.53-0.96)
Significant
Coomarasamy
et al 2002
Atosiban V placebo (2 trials)
Atosiban V beta-agonist (4 trials)
2 trials
RR 1.13,
(1.02-1.26)
Significant
4 trials
RR 1.07
(0.98-1.17)
Not significant
-
3 trials
RR 1.25
(1.09-1.44)
Significant
--
Crowther et al
2002
Magnesium sulphate V placebo/no
treatment or other tocolytic agent
11 trials
RR 0.85, (0.58-1.25)
Not significant
- No difference
reported
No difference
reported
King et al 2003 Calcium channel blockers V any other
tocolytic agent
- RR 0.76, (0.60-0.97)
Significant
RR 0.83, (0.69-0.99)
Significant
RR 0.95, (0.83-1.09)
Not significant
Anotayanonth
et al 2004
Betamimetics V Placebo 11 trials
RR 0.63, (0.53-0.75)
Significant
11 trials
RR 0.78, (0.68-0.90)
Significant
- 11 trials
RR 0.95, (0.88-1.03)
Not significant
King et al 2005 COX inhibitor V Placebo
COX inhibitor V any other tocolytic
2 trials
RR 0.20, CI 0.03-1.28
4 trials
RR 0.59, CI 0.34-1.02
2 trials
RR 0.41, CI 0.10-1.66
- 3 trials
RR 0.21, CI 0.07-0.62
3 trials
RR 0.53, CI 0.31-0.94
Whitworth &
Quenby 2008
Oral betamimetic V placebo - - - RR 1.07,
(0.14-8.09)
Not significant
2 Reprinted from the European Journal of Obstetrics & Gynecology and Reproductive Biology, Volume 142, Smith V, Devane D, Begley CM, Clarke M, Higgins S.A
systematic review and quality assessment of systematic reviews of randomised trials of interventions for preventing and treating preterm birth. 3-11, Copyright
(2009), with permission from Elsevier.
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review of reviews, highlighting the importance of having
clear reasons for conducting the review.
Conclusion
A systematic review of reviews allows the creation of a
summary of reviews in a single document. In this paper,
we have discussed the methods for conducting such a
review. The methods we have described and discussed
draw on our experiences, and should be useful to
healthcare practitioners who wish to conduct a systema-
tic review of reviews to enhance their evidence-based
knowledge and to support well-informed clinical deci-
sion making. They should also be useful to practitioners
who will find that the ideal starting point for knowledge
from research will be a systematic review of reviews of
the topic of interest to them.
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